TLDR:
- TVM Capital Life Science leads a €23 million Series C financing round for medical reporting pioneer, Smart Reporting.
- Proceeds will be focused on expanding international partnerships and product development, particularly in the US, Canada, Australia, and New Zealand.
TVM Capital Life Science, a prominent venture capital firm, has successfully closed a €23 million Series C financing round for Smart Reporting, a leader in medical reporting technology for radiology and pathology. The funding round was also supported by Bayern Kapital and existing investors. The primary focus of the funding will be to enhance international partnerships, further develop products, and strengthen market presence in key regions such as the US, Canada, Australia, and New Zealand. Smart Reporting’s innovative technology automates and streamlines medical documentation processes, creating valuable data in real-time while addressing the decreasing number of radiologists globally. The company’s software, “SmartReports,” offers a voice-controlled, data-driven documentation solution for doctors, paving the way for workflow automation and machine-readable data. Additionally, Smart Reporting has solidified its partnership with Solventum to enhance its presence in the international market, particularly in North America. With the additional capital, the company aims to accelerate its international growth strategy, especially after entering the US market. The successful financing round signifies strong support for Smart Reporting’s groundbreaking technology and its potential to become a global leader in radiology and pathology.
